20 results on '"Shaw, Kit L."'
Search Results
2. Induction of Fetal Hemoglobin and Reduction of Clinical Manifestations in Patients with Severe Sickle Cell Disease Treated with Shmir-Based Lentiviral Gene Therapy for Post-Transcriptional Gene Editing of BCL11A: Updated Results from Pilot and Feasibility Trial
3. Abstract CT540: A phase 1 trial of cytokine-induced memory-like (CIML) natural killer (NK) cell therapy with IL-15 superagonist in advanced head and neck cancer: Part 1 results
4. Phase 1 Study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma
5. Phase I Study of PHE885, a Fully Human BCMA-Directed CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma Manufactured in <2 Days Using the T-Charge TM Platform
6. Phase 1 Study of CD37-Directed CAR T Cells in Patients with Relapsed or Refractory CD37+ Hematologic Malignancies
7. Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiency
8. Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency
9. Busulfan Pharmacokinetics in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Gene Therapy
10. Lentiviral Gene Therapy with Autologous Hematopoietic Stem and Progenitor Cells (HSPCs) for the Treatment of Severe Combined Immune Deficiency Due to Adenosine Deaminase Deficiency (ADA-SCID): Results in an Expanded Cohort
11. Clinical efficacy of gene-modified stem cells in adenosine deaminase–deficient immunodeficiency
12. 240. Stable and Clinically Benign Clonal Dominance in an ADA-SCID Patient Treated With Retroviral Gene Therapy
13. 30. Phase II Clinical Trial of Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA-SCID) Using a γ-Retroviral Vector
14. Autologous Transplant/Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency
15. A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency
16. Gene therapy for adenosine deaminase–deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans
17. A Tale of Two SCIDs
18. 369. Development of an Amplifiable Gene Expression System in Lentivirus Vectors
19. Foamy Virus Envelope Glycoprotein Is Sufficient for Particle Budding and Release
20. Characterization of the R572T Point Mutant of a Putative Cleavage Site in Human Foamy Virus Env
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.